Arch Biopartners Inc. (ARCH)
TSXV
0.8700
0.00 (0.00%)
Closed
Oct 23, 2026
Day's Range
0.85000.8700
52 wk Range
0.39001.45
Financial Statements - ARCH - Arch Biopartners Inc.
Revenue
0
Net Income
-1.55M▲ 60.4%
EBITDA
-1.24M▲ 65.0%
Free Cash Flow
-1.58M▲ 32.0%
Income Statement
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -1.24M | -3.55M | -2.99M | -1.08M | -891.53K | -4.45M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -52.93K | 22.75K | 11.90K | -18.49K | -4.86K | 5.42K |
| Pre Tax Income | -1.55M | -3.92M | -3.32M | -1.40M | -1.16M | -4.62M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -1.55M | -3.92M | -3.32M | -1.40M | -1.16M | -4.62M |
| EPS Basic | -0.024 | -0.062 | -0.053 | -0.023 | -0.019 | -0.077 |
| EPS Diluted | -0.024 | -0.062 | -0.053 | -0.023 | -0.019 | -0.077 |
| Basic Shares Outstanding | 65.60M | 63.38M | 62.46M | 62.15M | 61.32M | 59.92M |
| Diluted Shares Outstanding | 65.60M | 63.38M | 62.46M | 62.15M | 61.32M | 59.92M |
| Ebit | -1.29M | -3.53M | -2.96M | -1.09M | -891.53K | -4.45M |
| Ebitda | -1.24M | -3.54M | -2.97M | -1.08M | -891.53K | -4.45M |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
